-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Maintains Overweight on Vera Therapeutics, Raises Price Target to $83

Benzinga·09/08/2026 15:47:41
語音播報
JP Morgan analyst Anupam Rama maintains Vera Therapeutics (NASDAQ:VERA) with a Overweight and raises the price target from $76 to $83.